Name Development Level Target Family
Name Description
neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
TCRDv5.2.0
DrugCentral Indication
neostigmine